Spread Bogatyr: The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology

Sponsor
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05543811
Collaborator
Group of companies EFKO (Other), Russian Science Foundation (Other)
140
1
2
5.5
25.7

Study Details

Study Description

Brief Summary

This is a single-centre, single-blind, two-arms, controlled study to assess the efficacy and safety of food for special dietary use enriched with 5-hydroxytryptophan, L-theanine and Gamma-aminobutyric acid in generally healthy subjects with no cognitive disturbances

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Food for special dietary use
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Disorders
Anticipated Study Start Date :
Sep 15, 2022
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Feb 28, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Product for special dietary use

Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid will be given to the subjects enrolled to this arm, 20 gram twice daily with breakfast and supper (instead of butter)

Dietary Supplement: Food for special dietary use
Food for special dietary use (spread) with modified ingredients' content will be included to the diet of 70 patients without significant organic pathology for 14 days receiving standard diet, modified by the inclusion of two portions of the spread, 20 grams each for breakfast and dinner

Placebo Comparator: control

This group will receive standard spread, without theanine, gamma-aminobutyric acid and 5-hydroxytryptophan, twice daily with breakfast and supper with food (instead of butter)

Dietary Supplement: Food for special dietary use
Food for special dietary use (spread) with modified ingredients' content will be included to the diet of 70 patients without significant organic pathology for 14 days receiving standard diet, modified by the inclusion of two portions of the spread, 20 grams each for breakfast and dinner

Outcome Measures

Primary Outcome Measures

  1. change in cognitive function [two weeks]

    change in score by Lurie test

  2. change in cognitive function2 [two weeks]

    change in Kraepelin&Schulte test score

  3. change in functional status [two weeks]

    change in functional status test score

  4. change in anxiety and depression [two weeks]

    change in Beck depression inventory score

Secondary Outcome Measures

  1. change in food's taste monotony [two weeks]

    change in food's taste monotony

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • willingness to participate;

  • age of 18-50 years

Exclusion Criteria:
  • pregnancy or breastfeeding;

  • significant somatic or psychological disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology Moscow Russian Federation 115446

Sponsors and Collaborators

  • Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
  • Group of companies EFKO
  • Russian Science Foundation

Investigators

  • Study Chair: Vasily Isakov, Professor, Federal Research Center of Nutrition and Biotechnology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
ClinicalTrials.gov Identifier:
NCT05543811
Other Study ID Numbers:
  • 19-76-30014/2022-HV
First Posted:
Sep 16, 2022
Last Update Posted:
Sep 19, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 19, 2022